Trials / Completed
CompletedNCT03080454
The Role of Trans-spinal Direct Current Stimulation (tsDCS) in Treating Patients With Hand Spasticity After Stroke
The Effect of Treatment With the PathMaker Myoregulator Neuromodulation System Incorporating Trans-spinal Direct Current Stimulation (tsDCS) in Patients With Severe Hand Spasticity After Stroke
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- Northwell Health · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate if 5 consecutive sessions of PathMaker anodal DoubleStim treatment, which combines non-invasive stimulation of the spinal cord (tsDCS- trans-spinal direct current stimulation) and of the median nerve at the peripheral wrist (pDCS-- peripheral direct current stimulation), can significantly reduce spasticity of the wrist and hand after stroke.
Conditions
- Stroke
- Cerebrovascular Accident (CVA)
- Hemiparesis
- Spasticity as Sequela of Stroke
- Muscle Spasticity
- Upper Extremity Paralysis
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | sham Doublestim | PathMaker MyoRegulator device |
| DEVICE | anodal Doublestim | PathMaker MyoRegulator device |
Timeline
- Start date
- 2016-09-01
- Primary completion
- 2018-03-01
- Completion
- 2018-03-01
- First posted
- 2017-03-15
- Last updated
- 2021-04-05
- Results posted
- 2019-09-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03080454. Inclusion in this directory is not an endorsement.